LEADER 03791nam 2200457z- 450 001 9910136800003321 005 20210212 035 $a(CKB)3710000000631122 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/57329 035 $a(oapen)doab57329 035 $a(EXLCZ)993710000000631122 100 $a20202102d2015 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aPsychomotor symptomatology in psychiatric illnesses 210 $cFrontiers Media SA$d2015 215 $a1 online resource (137 p.) 225 1 $aFrontiers Research Topics 311 08$a2-88919-725-5 330 $aPsychomotor symptoms are those symptoms that are characterized by deficits in the initiation, execution and monitoring of movements, such as psychomotor slowing, catatonia, neurological soft signs (NSS), reduction in motor activity or extrapyramidal symptoms (EPS). These symptoms have not always received the attention they deserve although they can be observed in a wide range of psychiatric illnesses, including mood disorders, psychotic disorders, anxiety disorders, pervasive developmental disorders and personality disorders. Nevertheless, these symptoms seem to have prognostic value on clinical and functional outcome in several pathologies. In the late 19th century, the founding fathers of modern psychiatry (including Kahlbaum, Wernicke, Kraepelin and Bleuler) had a strong focus on psychomotor abnormalities in their description and definitions of psychiatric illnesses and systematically recognized these as core features of several psychiatric pathologies. Nevertheless, emphasis on these symptoms has reduced substantially since the emergence of psychopharmacology, given the association between antipsychotics or antidepressants and medication-induced motor deficits. This has resulted in the general idea that most if not all psychomotor deficits were merely side effects of their treatment rather than intrinsic features of the illness. Yet, the last two decades a renewed interest in these deficits can be observed and has yielded an exponential growth of research into these psychomotor symptoms in several psychiatric illnesses. This recent evolution is also reflected in the increased appreciation of these symptoms in the DSM-5. As a result of this increased focus, new insights into the clinical and demographical presentation, the etiology, the course, the prognostic value as well as treatment aspects of psychomotor symptomatology in different illnesses has emerged. Still, many new questions arise from these findings. This research topic is comprised of all types of contributions (original research, reviews, and opinion piece) with a focus on psychomotor symptomatology in a psychiatric illness, especially research focusing on one or more of the following topics: the clinical presentation of the psychomotor syndrome; the course through the illness; the diagnostical specificity of the syndrome; the underlying neurobiological or neuropsychological processes; new assessment techniques; pharmacological or non-pharmacological treatment strategies. 606 $aMedicine$2bicssc 610 $aADHD 610 $aAffective Disorders 610 $aAlzheimer's disease 610 $aAutism Spectrum Disorder 610 $aBipolar Disorder 610 $aDepression 610 $aMotor Activity 610 $amotor control 610 $aMotor Cortex 610 $aSchizophrenia 615 7$aMedicine 700 $aManuel Morrens$4auth$01331570 702 $aSebastian Walther$4auth 906 $aBOOK 912 $a9910136800003321 996 $aPsychomotor symptomatology in psychiatric illnesses$93040442 997 $aUNINA